These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32141631)

  • 41. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
    Martínez-Estupiñán L; Hernández-Flórez D; Janta I; Ovalles-Bonilla JG; Nieto JC; González-Fernández CM; Del Río T; Monteagudo I; López-Longo FJ; Naredo E; Valor L
    Clin Exp Rheumatol; 2018; 36(1):88-93. PubMed ID: 28850020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.
    Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Antibodies to Prevotella copri in Anti-Cyclic Citrullinated Peptide-Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis.
    Seifert JA; Bemis EA; Ramsden K; Lowell C; Polinski K; Feser M; Fleischer C; Demoruelle MK; Buckner J; Gregersen PK; Keating RM; Mikuls TR; O'Dell JR; Weisman MH; Deane KD; Norris JM; Steere AC; Holers VM
    Arthritis Rheumatol; 2023 Apr; 75(4):507-516. PubMed ID: 36259174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden.
    Ärlestig L; Mullazehi M; Kokkonen H; Rocklöv J; Rönnelid J; Dahlqvist SR
    Ann Rheum Dis; 2012 Jun; 71(6):825-9. PubMed ID: 22128080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
    Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
    J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk.
    Sokolova MV; Hartmann F; Sieghart D; Bang H; Steiner G; Kleyer A; Schett G; Steffen U
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36717186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
    Cabrera-Villalba S; Gomara MJ; Cañete JD; Ramírez J; Salvador G; Ruiz-Esquide V; Hernández MV; Inciarte-Mundo J; Haro I; Sanmartí R
    Arthritis Res Ther; 2017 Jun; 19(1):141. PubMed ID: 28619044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rheumatoid arthritis and the proinflammatory cytokine IL-17.
    Selimov P; Karalilova R; Damjanovska L; Delcheva G; Stankova T; Stefanova K; Maneva A; Selimov T; Batalov A
    Folia Med (Plovdiv); 2023 Feb; 65(1):53-59. PubMed ID: 36855974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis.
    Manoil D; Courvoisier DS; Gilbert B; Möller B; Walker UA; Muehlenen IV; Rubbert-Roth A; Finckh A; Bostanci N
    Rheumatology (Oxford); 2021 Oct; 60(10):4755-4764. PubMed ID: 33512428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.
    Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A
    Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-citrullinated protein antibodies suppress let-7a expression in monocytes from patients with rheumatoid arthritis and facilitate the inflammatory responses in rheumatoid arthritis.
    Lai NS; Yu HC; Yu CL; Koo M; Huang HB; Lu MC
    Immunobiology; 2015 Dec; 220(12):1351-8. PubMed ID: 26227320
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Hiwa R; Ikari K; Ohmura K; Nakabo S; Matsuo K; Saji H; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Yamanaka H; Matsuda F; Mimori T; Terao C
    J Rheumatol; 2018 Apr; 45(4):470-480. PubMed ID: 29419463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti-Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis.
    Okamoto Y; Devoe S; Seto N; Minarchick V; Wilson T; Rothfuss HM; Mohning MP; Arbet J; Kroehl M; Visser A; August J; Thomas SM; Charry LL; Fleischer C; Feser ML; Frazer-Abel AA; Norris JM; Cherrington BD; Janssen WJ; Kaplan MJ; Deane KD; Holers VM; Demoruelle MK
    Arthritis Rheumatol; 2022 Jan; 74(1):38-48. PubMed ID: 34369110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study.
    Klaasen R; Cantaert T; Wijbrandts CA; Teitsma C; Gerlag DM; Out TA; de Nooijer MJ; Baeten D; Tak PP
    Rheumatology (Oxford); 2011 Aug; 50(8):1487-93. PubMed ID: 21454308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
    Brickmann K; Brezinschek RI; Yazdani-Biuki B; Graninger WB; Brezinschek HP
    Clin Exp Rheumatol; 2010; 28(6):888-91. PubMed ID: 21205465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extramucosal Formation and Prognostic Value of Secretory Antibodies in Rheumatoid Arthritis.
    Martinsson K; Kling LL; Roos-Ljungberg K; Griazeva I; Samoylovich M; Paul S; Rönnelid J; Weitoft T; Wetterö J; Kastbom A
    Arthritis Rheumatol; 2022 May; 74(5):801-809. PubMed ID: 34927393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.